References
- Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255–267.
- Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006; 9: 340–345.
- Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33: 1387–1392.
- Ramage G, Saville SP, Thomas DP, López-Ribot JL. Candida biofilms: an update. Eukaryot Cell 2005; 4: 633–638.
- Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006; 6: 979–986.
- El-Azizi MA, Starks SE, Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol 2004; 96: 1067–1073.
- López-Ribot JL. Candida albicans biofilms: more than filamentation. Curr Biol 2005; 15: 453–455.
- Nobile CJ, Andes DR, Nett JE, . Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006; 2: 63–
- Hogan DA. Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryot Cell 2006; 5: 613–619.
- Verstrepen KJ, Klis FM. Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 2006; 60: 5–15.
- Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10: 14–19.
- Chandra J, Kuhn DM, Mukherjee PK, . Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385–5394.
- Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 2001; 18: 163–170.
- Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006; 9: 588–594.
- Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 2002; 46: 3499–3505.
- Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002; 70: 878–888.
- Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255–267.
- De Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi, 2nd. Utrecht, Reus: Centraalbureau voor Schimmelcultures, Universitat Rovira i Virgili, 2000.
- Tumbarello M, Posteraro B, Trecarichi EM, . Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 2007; 45: 1843–1850.
- Presterl E, Daxböck F, Graninger W, Willinger B. Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect 2007; 13: 1072–1076.
- Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004; 23: 635–641.
- Rao S, Ali U. Systemic fungal infections in neonates. J Postgrad Med 2005; 51: 27–29.
- Parikh TB, Nanavati RN, Patankar CV, . Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr 2007; 44: 830–837.
- Sbarbati A, Fanos V, Bernardi P, Tatò L. Rapid diagnosis of fungal infection of intravascular catheters in newborns by scanning electron microscopy. Scanning 2001; 23: 376–378.
- Ramage G, Tomsett K, Wickes BL, López-Ribot JL, Redding SW. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 53–59.
- Avon SL, Goulet JP, Deslauriers N. Removable acrylic resin disk as a sampling system for the study of denture biofilms in vivo. J Prosthet Dent 2007; 97: 32–38.
- Laffey SF, Butler G. Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology 2005; 151: 1073–1081.